Get started

Seaside Therapeutics (United States)

Alternate names: Seaside Therapeutics, Seaside Therapeutics, Inc.
ROR: 052kdgw11
OpenAlex ID: I4405281915
Effects of STX209 (Arbaclofen) on Neurobehavioral Function in Children and Adults with Fragile X Syndrome: A Randomized, Controlled, Phase 2 Trial
2012 · Elizabeth M. Berry-Kravis, David Hessl, et al. · Science Translational Medicine · 343
Reversal of Disease-Related Pathologies in the Fragile X Mouse Model by Selective Activation of GABA B Receptors with Arbaclofen
2012 · Christina Henderson, Lasani Wijetunge, et al. · Science Translational Medicine · 261
Arbaclofen in fragile X syndrome: results of phase 3 trials
2017 · Elizabeth Berry-Kravis, Randi Hagerman, et al. · Journal of Neurodevelopmental Disorders · 190
PDF
Arbaclofen in Children and Adolescents with Autism Spectrum Disorder: A Randomized, Controlled, Phase 2 Trial
2016 · Jeremy Veenstra-VanderWeele, Edwin H Cook, et al. · Neuropsychopharmacology · 179
PDF
Dendritic ion channel trafficking and plasticity
2010 · Mala M. Shah, Rebecca S. Hammond, et al. · Trends in Neurosciences · 142
STX209 (Arbaclofen) for Autism Spectrum Disorders: An 8-Week Open-Label Study
2013 · Craig A. Erickson, Jeremy M. Veenstra-Vanderweele, et al. · Journal of Autism and Developmental Disorders · 130
Mechanism-based approaches to treating fragile X
2010 · Gül Dölen, Randall L. Carpenter, et al. · Pharmacology & Therapeutics · 130
High-Throughput Sequencing of mGluR Signaling Pathway Genes Reveals Enrichment of Rare Variants in Autism
2012 · Raymond J. Kelleher III, Ute Geigenmüller, et al. · PLoS ONE · 125
PDF
The effects of l-amphetamine sulfate on cognition in MS patients: results of a randomized controlled trial
2009 · Sarah A. Morrow, Tanya Kaushik, et al. · Journal of Neurology · 76
Modulation of behavioral phenotypes by a muscarinic M1 antagonist in a mouse model of fragile X syndrome
2011 · Surabi Veeraragavan, Nghiem Bui, et al. · Psychopharmacology · 64
Effects of l-amphetamine sulfate on cognitive function in multiple sclerosis patients
2008 · R. H. B. Benedict, F. Munschauer, et al. · Journal of Neurology · 53
The Role of Aldehyde Oxidase and Xanthine Oxidase in the Biotransformation of a Novel Negative Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 5
2012 · Ryan D. Morrison, Anna L. Blobaum, et al. · Drug Metabolism and Disposition · 44
PDF
Metabolic and Pharmacokinetic Differentiation of STX209 and Racemic Baclofen in Humans
2012 · Raymundo Sanchez-Ponce, Li-Quan Wang, et al. · Metabolites · 32
PDF
Fragile X Syndrome: An Update on Developing Treatment Modalities
2011 · Aileen Healy, Roger Rush, et al. · ACS Chemical Neuroscience · 19
Antagonism of chemokine receptor CCR8 is ineffective in a primate model of asthma
2013 · Lin Wang, Tracy J Jenkins, et al. · Thorax · 17
PDF
Cognitive Development Considerations for Long-term Safety Exposures in Children
2013 · Mary Pipan, Paul P. Wang, et al. · Wiley eBooks · 2
Emerging Research towards the Understanding and Treatment of Autism
2012 · Paul Wang, Rebecca Hammond, et al. · Royal Society of Chemistry eBooks · 1
Works count: 17
Citation count: 7,028
Year
Topic
Type